Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
October 20th, 2018
19.8K views
Here, we present a protocol that describes the fabrication of stretchable, dual channel, organ chip microfluidic cell culture devices for recapitulating organ-level functionality in vitro.
Overview
This protocol describes the fabrication of stretchable, dual channel, organ chip microfluidic cell culture devices. These devices are designed to recapitulate organ-level functionality in vitro, mimicking physiological conditions.
Key Study Components
Area of Science
- Microfluidics
- Cell culture
- Organ-on-a-chip technology
Background
- Organ chips are used to simulate organ functions in vitro.
- Mechanical cues are important for tissue development.
- 3D printing allows for precise mold fabrication.
- These devices can mimic blood flow and other bodily fluid dynamics.
Purpose of Study
- To fabricate organ chipped devices that replicate organ-level functions.
- To understand complex physiological processes in vivo.
- To provide a platform for studying organ-specific responses.
Methods Used
- 3D printing of molds using soft silicon rubber.
- Integration of mechanical stretching capabilities.
- Incorporation of perfusion systems to mimic blood flow.
- Testing the functionality of the fabricated devices.
Main Results
- Successful fabrication of stretchable organ chip devices.
- Devices demonstrated the ability to mimic organ-level functions.
- Mechanical cues positively influenced tissue behavior.
- Perfusion systems effectively replicated fluid dynamics.
Conclusions
- The protocol provides a reliable method for organ chip fabrication.
- These devices can enhance the understanding of organ physiology.
- Potential applications in drug testing and disease modeling.
Frequently Asked Questions
What are organ chips?
Organ chips are microfluidic devices that simulate the functions of human organs in vitro.
How are the devices fabricated?
The devices are fabricated using 3D printed molds made from soft silicon rubber.
What is the significance of mechanical cues?
Mechanical cues are crucial for tissue development and function, mimicking the natural environment of organs.
What does perfusion mimic in these devices?
Perfusion mimics blood flow and the movement of bodily fluids, essential for organ functionality.
What are potential applications of these organ chips?
They can be used for drug testing, disease modeling, and understanding organ-specific responses.
Executive Industry Relevance
Human Organ-on-a-Chip technology addresses a critical bottleneck in drug development by providing human-relevant in vitro models that better predict clinical outcomes than animal studies. This scalable fabrication protocol enables reproducible production of stretchable, dual-channel microfluidic devices for mechanistic de-risking of therapeutic candidates. By recapitulating organ-level physiology and mechanical cues, the technology supports target validation and predictive confidence in early discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through human tissue-tissue interactions on porous membranes.
- Operational Value: Supports functional target validation by modeling organ-specific mechanical cues and perfusion.
- Predictive Value: Enhances confidence in target engagement by recapitulating in vivo-like barrier and transport functions.
Screening & Assay Development
- Scientific Value: Provides standardized, reproducible microfluidic platforms for compound screening with physiological flow and strain.
- Operational Value: Enables assay readiness through scalable fabrication using 3D printed molds and polycarbonate carriers.
- Throughput Value: Facilitates parallel testing of dual tissue types under controlled mechanical and perfusion conditions.
Translational & Preclinical Research
- Scientific Value: Bridges discovery to preclinical by modeling human organ-level responses to therapeutics and pathogens.
- Operational Value: Supports risk-adjusted advancement decisions through quantitative permeability and barrier integrity measurements.
- Translational Continuity: Aligns with biomarker studies by enabling metabolite and protein flux analysis across tissue interfaces.
Pipeline & Workflow Integration
The fabrication method integrates into early discovery workflows by enabling rapid prototyping of organ-specific chips for hypothesis testing and lead compound evaluation.
- Discovery Biology: Supports mechanistic de-risking by modeling tissue-tissue interactions under physiological strain and flow.
- Screening: Delivers assay standardization and reproducibility through molded channels and consistent membrane porosity.
- Analytics: Enables quantitative readouts such as apparent permeability and barrier function for compound comparison.
- Translational Research: Connects to preclinical validation via human-relevant organ-level physiology and cyclic mechanical actuation.
- Enterprise Reuse: Positions the fabrication platform as a reusable capability for multi-organ chip generation and storage.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through human-relevant organ-chips that reduce mechanistic ambiguity in target validation.
- Operational Value: Standardization and scalability via 3D printed molds and polycarbonate carrier-based handling.
- Strategic Value: Improved go/no-go decisions by reducing late-stage biological risk through early human-relevant efficacy and toxicity profiling.
- Portfolio Impact: Enables risk-adjusted prioritization of leads based on organ-chip-derived permeability and barrier data.
Implementation Considerations
- Requires expertise in microfluidic device assembly, plasma bonding, and tissue culture under mechanical stimulation.
- Depends on access to vacuum desiccators, ovens, laminar flow hoods, and 3D printing for mold generation.
- Necessitates cross-team standardization of membrane porosity thresholds and perfusion parameters for reproducible results.
- Involves adaptation considerations when extending the platform to different organ types with varying mechanical and biochemical cues.
- Practical limitations include manual handling steps during membrane inspection and top-to-membrane alignment under microscopy.
Biopharma FAQs
Why does membrane permeability measurement matter for target validation?
Measuring apparent permeability using di-concentration in outlet channels with and without Caco-2 cells quantifies barrier function, which informs target engagement predictions and helps de-risk therapeutic candidates by modeling human-relevant transport properties.
How does independent variable isolation of cyclic strain support discovery pipeline decisions?
Isolating cyclic vacuum actuation as an independent variable enables reproducible application of mechanical strain to the membrane, allowing teams to assess its specific impact on tissue differentiation and organ-level function without confounding perfusion effects.
What quantitative dependent variable measurements enable mechanistic de-risking?
Dependent variables such as metabolite flux, protein transport, and cellular differentiation (e.g., villi formation) provide quantitative readouts that help teams evaluate mechanism of action and pathway modulation under physiological conditions.
Why do replication requirements matter for cross-functional collaboration in organ-chip studies?
Replication through standardized fabrication using 3D printed molds and polycarbonate carriers ensures consistent device performance, enabling reliable data sharing between discovery, toxicology, and translational teams for aligned go/no-go assessments.
What statistical analysis capabilities are required before implementing organ-chip data in lead selection?
Teams require the ability to analyze permeability coefficients, barrier integrity metrics, and strain-responsive biological outputs using comparative statistics to distinguish significant compound effects from variability and support evidence-based advancement decisions.
